Roundtable: Other Rare Disorders Associated with Pulmonary Hypertension

2015 ◽  
Vol 14 (3) ◽  
pp. 161-165
Keyword(s):  
Pulmonary Hypertension ◽  
Medical School ◽  
Guest Editor ◽  
Harvard Medical School ◽  
Medical Center ◽  
Rare Disorders ◽  
University Of Texas ◽  
School Of Medicine ◽  
University Of Cincinnati ◽  
Washington University

While pulmonary hypertension itself is a rare disorder, its association has been identified in conjunction with other rare disorders, which is the theme of this issue of Advances in Pulmonary Hypertension. Co-guest editor Sonja Bartolome, MD, facilitated a discussion regarding the experiences and perceptions of leading PH experts—many authors in this issue—on this topic. Participating were co-guest editor Kelly Chin, MD, University of Texas Southwestern Medical Center; Murali Chakinala, MD, Washington University School of Medicine; Richard Channick, MD, Harvard Medical School; Jean Elwing, MD, University of Cincinnati Medical Center; and adding to the comments later, Robert Baughman, MD, University of Cincinnati. Their conversation follows.

scholarly journals Pulmonary Hypertension Roundtable: The Role of Exercise in Clinical Practice and Clinical Trials

2019 ◽  
Vol 18 (2) ◽  
pp. 63-67
Keyword(s):  
Clinical Trials ◽  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Clinical Practice ◽  
Los Angeles ◽  
Guest Editor ◽  
Harvard Medical School ◽  
Medical Center ◽  
Professor Emeritus

On May 20, 2019, Guest Editor Ronald Oudiz, MD, Director of the Pulmonary Hypertension Program at Harbor-UCLA Medical Center in Los Angeles, California, led a discussion with Aaron Waxman, MD, PhD, Director of the Center for Pulmonary Heart Disease at Brigham and Women's Hospital and Harvard Medical School in Boston, Massachusetts, and Robert Naeije, MD, Professor Emeritus at the Free University of Brussels, Belgium.

scholarly journals PH Roundtable: Pulmonary Hypertension Roundtable: Clinical Experiences With Drug- and Toxin-Related PH

2018 ◽  
Vol 17 (2) ◽  
pp. 80-85
Keyword(s):  
Pulmonary Hypertension ◽  
Medical Center ◽  
Assistant Professor ◽  
Associate Professor ◽  
Texas Southwestern Medical ◽  
Clinical Experiences ◽  
University Of Texas ◽  
School Of Medicine ◽  
Hypertension Clinic ◽  
The University

Sonja Bartolome, MD, pulmonary hypertension specialist and Director of Liver Transplant Critical Care at University of Texas Southwestern Medical Center, Dallas, facilitated a comprehensive discussion among 4 additional clinical experts regarding their experiences with the broad-ranging issues related to treating patients with drug- and toxin-related pulmonary hypertension. Joining the call on May 3, 2018, were Vinicio de Jesus Perez, MD, Assistant Professor of Medicine and staff physician and Roham Zamanian, MD, Associate Professor of Medicine and Medical Director, from the Pulmonary Hypertension Clinic at Stanford University School of Medicine; Kelly Chin, MD, Director of the Pulmonary Hypertension Center at University of Texas Southwestern Medical Center; and Konstadina Darsaklis, MD, Assistant Professor at the University of Connecticut, and cardiologist at Hartford Hospital where she started the pulmonary hypertension clinic.

scholarly journals Exploring the Spectrum of Pathology and Treatment in Portopulmonary Hypertension: Four Experts Address the Toughest Questions

2004 ◽  
Vol 3 (2) ◽  
pp. 20-24 ◽  
Author(s):  
Ronald J. Oudiz ◽  
Michael J. Krowka ◽  
Russell Wiesner ◽  
Michael Ramsey
Keyword(s):  
Pulmonary Hypertension ◽  
Critical Care ◽  
Pain Management ◽  
Mayo Clinic ◽  
Medical Center ◽  
Associate Professor ◽  
Portopulmonary Hypertension ◽  
University Of Texas ◽  
Baylor University ◽  
School Of Medicine

This discussion was moderated by Ronald J. Oudiz, MD, Associate Professor of Medicine, David Geffen School of Medicine at UCLA, and Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, Harbor-UCLA Medical Center, Torrance, California. The participants included Michael J. Krowka, MD, Professor of Medicine, and Russell Wiesner, MD, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, and Michael Ramsay, MD, FRCA, Chairman, Department of Anesthesiology and Pain Management, Baylor University Medical Center, and Clinical Professor, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas, Texas.

Using Advanced Pulmonary Hypertension Therapies in Children

2011 ◽  
Vol 10 (2) ◽  
pp. 117-124
Author(s):  
Erika Rosenzweig ◽  
Dunbar Ivy ◽  
Maurice Beghetti ◽  
Jeffrey Feinstein
Keyword(s):  
Pulmonary Hypertension ◽  
Guest Editor ◽  
Pediatric Cardiology ◽  
Associate Professor ◽  
University Hospital ◽  
Stanford University ◽  
New Therapies ◽  
University Of Toronto ◽  
University Of Colorado ◽  
School Of Medicine

On July 8, 2011, Editor-in-Chief Erika Rosenzweig convened a discussion among a group of physicians who work daily with pediatric PH patients to share their thoughts and experiences related to using new therapies with children. Contributing to the conversation were guest editor Dunbar Ivy, MD, Professor of Pediatrics, University of Colorado; Jeffrey A. Feinstein, MD, MPH, Associate Professor, Stanford University School of Medicine; Tilman Humpl, MD, PhD, Associate Professor, Pediatrics, University of Toronto; and Professor Maurice Beghetti, Head of Pediatric Subspecialties Division and Head of Pediatric Cardiology Unit, Children's University Hospital, Geneva, Switzerland.

Pulmonary Hypertension Roundtable: COPD, IPF, and Pulmonary Hypertension: A Clinician's Dilemma

2013 ◽  
Vol 12 (3) ◽  
pp. 145-151
Keyword(s):  
Pulmonary Hypertension ◽  
Rhode Island ◽  
Medical Center ◽  
Puget Sound ◽  
Health Science ◽  
Pulmonary Vascular Disease ◽  
University Hospitals ◽  
Science Center ◽  
University Of Texas ◽  
Transplant Program

On October 9, 2013, a group of experts met by telephone to discuss PH in the setting of COPD and IPF. The group consisting of guest editor of this issue Jeffrey Edelman, MD, Head, Lung Transplant Program VA Puget Sound Health System, University of Washington; Deborah J. Levine, MD, Director, Pulmonary Hypertension Center, University of Texas Health Science Center at San Antonio; James Klinger, MD, Director, Rhode Island Hospital Pulmonary Hypertension Center; and Robert Schilz, DO, PhD, Director of Pulmonary Vascular Disease and Lung Transplantation, University Hospitals, Case Medical Center; provided perspective and insight into how clinicians can approach these patients most effectively.

Roundtable: Pulmonary Hypertension Due to Left Heart Disease

2015 ◽  
Vol 14 (2) ◽  
pp. 105-110
Keyword(s):  
Pulmonary Hypertension ◽  
Heart Disease ◽  
Guest Editor ◽  
Mayo Clinic ◽  
Diagnosis And Treatment ◽  
Left Heart ◽  
Health Network ◽  
University Of Utah ◽  
School Of Medicine ◽  
Left Heart Disease

Guest editor Teresa De Marco, MD, along with Brian Shapiro, MD, Mayo Clinic, Jacksonville, FL, convened a panel of experts to discuss the challenges in diagnosis and treatment and the emerging science regarding pulmonary hypertension due to left heart disease. Contributing to the engaging discussion were James Fang, MD, University of Utah School of Medicine; Barry Borlaug, MD, Mayo Clinic, Rochester, MN; and Srinivas Murali, MD, Allegheny Health Network, Pittsburgh, PA.

Sign in / Sign up

Export Citation Format

Share Document